Assessment of genotoxicity and mutagenicity of 1,2-dioxetanes in human cells using a plasmid shuttle vector.
1,2-Dioxetanes are efficient sources of triplet excited carbonyl compounds on thermal decomposition. They cause photochemical and photobiological transformations in the dark. In order to study the genotoxicity and mutagenicity of 1,2-dioxetanes, the replicating shuttle vector pZ189 was damaged with 3,3,4-trimethyl-1,2-dioxetane (TrMD) or 3-hydroxymethyl-3,4,4-trimethyl-1,2-dioxetane (HTMD) in vitro and subsequently transfected into normal human lymphoblasts. We found a dose-dependent increase of genotoxicity (decrease of plasmid survival) and increase of mutation frequency with both dioxetanes. However, TrMD was less mutagenic than HTMD at similar genotoxicity. Sequence analysis of the supF gene revealed more point mutations with TrMD and 100% with HTMD were G:C to T:A and G:C to C:G transversions. These are the typical mutations following 7,8-dihydro-8-oxoguanine (8-oxo-G) formation, the main DNA lesion induced by TrMD and HTMD. Only with TrMD we found 5.4% G:C to A:T transitions, probably reflecting the more pronounced ability of TrMD to form some pyrimidine dimers. Our results indicate that 8-oxo-G is also the most relevant modification in in vivo mutagenesis.
Emmert
S
S
Department of Dermatology, University of Würzburg, Germany.
Epe
B
B
Saha-Möller
C R
CR
Adam
W
W
Rünger
T M
TM
D001483:Base Sequence; D002461:Cell Line, Transformed; D004247:DNA / Q000187:drug effects; D004252:DNA Mutational Analysis; D005822:Genetic Vectors; D006571:Heterocyclic Compounds / Q000633:toxicity*; D006573:Heterocyclic Compounds, 1-Ring; D006801:Humans; D008969:Molecular Sequence Data; D009152:Mutagenicity Tests; D009153:Mutagens / Q000633:toxicity*; D017354:Point Mutation
D006571:Heterocyclic Compounds; D006573:Heterocyclic Compounds, 1-Ring; D009153:Mutagens; C079142:1,2-dioxetane; D004247:DNA